Biopool International
This article was originally published in The Gray Sheet
Executive Summary
Test kit manufacturer nets approximately $2 mil. from private placement of 1.2 mil. shares of unregistered common stock at $1.875 per share. Purchasers were Stamford, Connecticut-based International Capital Partners and San Francisco-based VK Capital Co. Proceeds from the offering will be used by the Ventura, California-based firm "to pay down existing debt, to purchase capital equipment and fund other corporate expenditures," and for R&D and marketing efforts. Van Kasper & Co. acted as placement agent for the transaction.